Organic Chemistry Methods TRIZ Cases

Benzoimidazole indolyl methane compounds reduce PCSK9 protein levels in human hepatoma cells.

Iridium-catalyzed asymmetric hydrogenation replaces inefficient resolution methods, achieving over 90% yield and high optical purity for drug development.

Specific host material combinations resolve the trade-off between high driving voltage and short lifespan in organic electroluminescent devices.

Introducing a polycyclic compound dopant with triazine groups resolves the trade-off between luminous efficiency and lifespan in display devices.

Propargyl amino acid esters inhibit cystathionine-gamma-lyase, reducing hydrogen sulfide synthesis to attenuate carotid body chemoreflex and treat sleep apnea.

Radiolabeled CD8 minibodies visualize low-density tumor infiltrating lymphocytes via PET, guiding immunotherapy selection.

A valsartan refining method uses pH adjustment and organic solvent extraction to crystallize the product.

Specific isoindolinone compounds selectively inhibit the MDM2-p53 interaction, resolving the trade-off between anticancer activity and effects on normal cells.

Formula I compounds cross the blood-brain barrier to treat brain and leptomeningeal metastases in HER2-positive breast cancer patients.

Tetradentate organometallic compounds with platinum or palladium centers emit light in organic layers.

Specific polymorphic structures of the PI3K inhibitor enhance bioavailability and chemical stability for treating leukemia.

Incorporating a deuterated compound in blue phosphorescent OLEDs extends lifespan and stabilizes driving voltage for medium-sized panels.

Characterizing crystal form III with specific X-ray diffraction peaks resolves stability and bioavailability issues in antiviral drug manufacturing.

A platinum carbazole compound enhances emission properties in organic light emitting diodes.

Direct contact between distinct emitting layers extends device lifetime by resolving trade-offs between drive voltage and structural complexity.

Adding alkali to the second distillation column neutralizes hydrogen iodide, preventing condensation and reducing corrosion.

Converting liquid fermented ammonium lactate to solid calcium lactate crystals solves shipping storage constraints while maintaining high protein content.

An organometallic compound with a high triplet metal-centered energy value enables stable deep blue light emission in light-emitting devices.

Replacing toxic phosphorus reagents with safer alternatives to synthesize high-purity linagliptin impurities for precise quality control.

Directly grafting calix[n]arenes prevents disorganized multilayers and improves vertical control during deposition.

Controlled temperature gradients and specific solvent systems resolve purity-yield contradictions in cannabinoid extraction.

Deuterated organic compounds in the light-emitting layer reduce non-radiative transitions, extending device lifetime while maintaining high emission efficiency.

Composite host materials reduce driving voltage and extend lifespan by resolving contradictions between device complexity and performance.

Dry powder formulation eliminates screen clogging in injection systems while delivering vitamins and microbes to enhance root development.

A co-supported ruthenium-palladium catalyst enables aromatic ring hydrogenation to produce alicyclic carboxylic acids.

Composite host-guest materials resolve the efficiency-lifespan trade-off by balancing energy levels for reduced driving voltage and extended operational life.

Deuterated biphenyl compounds in hole transport layers reduce lateral leakage and client-side crosstalk while improving luminous efficiency and device lifespan.

High HOMO or LUMO host materials in the blue emitting layer increase blue light intensity and color temperature, resolving suboptimal luminous properties.

Optimized molecular parameters reduce driving voltage and boost power efficiency in medium-sized OLED panels.

Saturated solvent vapor deposits onto milled tiotropium bromide solvates to restore crystalline equilibrium.

Solution-processable host compounds resolve solubility-reliability contradictions, improving luminous efficiency and lifespan in large displays.

A light emitting element uses an organometallic compound with a condensed ring structure to stabilize the emission layer.

A Mirabegron crystallization process using controlled cooling and antioxidants to yield stable alpha-form crystals.

A method combines zinc chloride with lysine in aqueous solution to form a zinc-lysine complex.

Acidic compounds selectively convert oximino compound isomer mixtures into high-purity E or Z forms, bypassing complex physical purification steps.

Benzoxazole heterocyclic compounds prevent pi-pi stacking to extend device lifetime and improve thermal stability.

Optimizing pore size and crystallite dimensions reduces ammonia combustion rates while maintaining fluidity for efficient fluidized-bed production.

Amino acid protecting groups with water-solubility enhancing features enable peptide bond formation in environmentally friendly solvents.

A light emitting layer combines host and guest organic compounds to enhance charge transport and exciton utilization.

Crystalline ALK2 inhibitor compounds overcome ligand structural diversity to achieve specific BMP pathway inhibition.

A heterocyclic compound delocalizes HOMO orbitals to lower driving voltage in organic light-emitting devices.

A carbonylation reactor process maintains specific rhodium catalyst and methyl iodide concentrations to produce acetic acid.

Controlling carbonyl and acetal compound concentrations prevents catalyst deactivation during continuous 2,5-dihydrofuran production.